BPI 2026 has ended. This guide stays up as the record of who was there. Next: BPI 2027, Sep 20–23, 2027 in Boston
AstraZeneca at BPI 2026
Sep 22–25, 2026 Boston, MA ~3k attendees Website
AstraZeneca takes part in 8 sessions at BPI 2026 in Boston. Its program pairs continuous and intensified processing with predictive process control. Work covers high-throughput chemically defined media and feed optimization, predicting the impact of diversions in a dynamic continuous process, and the cell culture levers that shape antibody-drug conjugate loading.
| Organization | BPI 2026 Attendance |
|---|---|
AstraZeneca Cambridge, United Kingdom | |
Global pharmaceutical company developing and manufacturing biologics, including antibodies and antibody-drug conjugates. | Panel Tue Sep 22 11:30am–12:00pm Keynote Wed Sep 23 9:00am–9:30am Keynote Wed Sep 23 5:00pm–5:45pm PLENARY KEYNOTE: Integrated and Continuous Bioprocessing: what’s holding us back, and where do we go from here? Upstream & Cell CultureDownstream Processing Talk Thu Sep 24 12:00pm–12:30pm Talk Fri Sep 25 11:15am–11:45am Talk Fri Sep 25 2:00pm–2:30pm Talk Fri Sep 25 2:30pm–3:30pm Talk Fri Sep 25 2:30pm–3:30pm |
Find decision makers at AstraZeneca
Tell us what you sell and we’ll find the people at AstraZeneca most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the BioProcess International Conference & Exhibition or its organizers. Submit a correction